Video Experimental Relacionado
Updated: Dec 27, 2025
09:57
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
3.3K
Epilepsia en personas mayores
Arjune Sen1, Nathalie Jette2, Masud Husain3
1Oxford Epilepsy Research Group, National Institute for Health Research Oxford Biomedical Research Centre, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Lancet (London, England)
|March 2, 2020
Resumen
La epilepsia afecta a muchos adultos mayores, pero la investigación a menudo pasa por alto este grupo demográfico. Esta revisión pone de relieve la necesidad de un mejor diagnóstico, tratamiento y ensayos clínicos inclusivos para la epilepsia en personas mayores.
Área de la Ciencia:
- Medicina para la edad avanzada
- Neurología
- Salud pública
Sus antecedentes:
- Las poblaciones que envejecen en todo el mundo se enfrentan a desafíos de atención médica, especialmente para las personas mayores.
- La epilepsia, caracterizada por convulsiones recurrentes, es prevalente en adultos mayores de 65 años, pero recibe poca atención en la investigación.
- La comprensión de la epilepsia en adultos mayores es crucial para la prestación efectiva de atención médica.
Objetivo del estudio:
- Revisar las causas, el diagnóstico y el tratamiento de la epilepsia en adultos mayores.
- Explorar las comorbilidades y los impactos psicosociales de la epilepsia en los ancianos.
- Abogar por ensayos clínicos inclusivos y estrategias preventivas para la epilepsia en personas mayores.
Principales métodos:
- Revisión exhaustiva de la literatura sobre epilepsia en adultos mayores.
- Análisis de los desafíos de diagnóstico y las opciones de tratamiento (medicamentos y cirugía).
- Evaluación de los factores cognitivos, psicológicos y psicosociales, teniendo en cuenta las disparidades económicas mundiales.
Principales resultados:
- Causas específicas identificadas y dificultades de diagnóstico de la epilepsia en ancianos.
- Discutieron medicamentos apropiados contra las convulsiones y intervenciones quirúrgicas.
- Se examinó la influencia de la epilepsia en las redes sociales y de atención en diferentes países de ingresos.
Conclusiones:
- Hace hincapié en la necesidad de una mayor inclusión de adultos mayores en ensayos clínicos de epilepsia.
- Sugiere que mejorar los factores de riesgo vascular puede reducir la incidencia de epilepsia en las personas mayores.
- Pide estrategias de atención sanitaria adaptadas para hacer frente a la epilepsia en la población de edad avanzada.
Videos de Conceptos Relacionados
01:24Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
01:13Seizures: Classification
1.2K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
01:20Antiepileptic Drugs: Potassium Channel Activators
544
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
544
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.1K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
144
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
144
01:14Antiepileptic Drugs: Glutamate Antagonists
809
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
809